每次测试成本的关键驱动因素

包含两种结核病耐药检测MC-NAAT的成本数据及其驱动因素分析,用于评估成本效益。

Figshare
2023-08-24 更新
浏览 28
表格performance profiles suitablehigh burden countriesdrug resistant testingannual testing volumes000 per yearresource limited settingtesting volume levelstests per rundifferent testing throughputxlink "> accessprocured equipment costsmoderate complexity naats
Key drivers of per test cost.

基本信息

模态
表格
大小
0.000005632 GB
许可
CC BY 4.0
创建/更新时间
2023-08-24
版本
v1

资源简介

每次测试成本的关键驱动因素

【数据集背景】

本数据集源站标题为《Key drivers of per test cost.》。源站首次发布:2023-08-24。

【数据内容】

源站原始描述:Background Access to drug resistant testing for tuberculosis (TB) remains a challenge in high burden countries. Recently, the World Health Organization approved the use of several moderate complexity automated nucleic acid amplification tests (MC-NAAT) that have performance profiles suitable for placement in a range of TB laboratory tiers to improve drug susceptibility tests (DST) coverage. Methods We conducted cost analysis of two MC-NAATs with different testing throughput: Lower Throughput (LT…

【数据结构与技术规格】

文件数 1 个,合计 5.63 KB。Table 1.xls:application/vnd.ms-excel,5.63 KB。数据集 DOI:10.1371/journal.pone.0290496.t001。

【主题与分类】

源站学科分类:Medicine、Genetics、Pharmacology、Biotechnology、Science Policy、Infectious Diseases。主题标签:performance profiles suitable、high burden countries、drug resistant testing、annual testing volumes、000 per year、resource limited setting、testing volume levels、tests per run、different testing throughput、xlink "> access。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://plos.figshare.com/articles/dataset/Key_drivers_of_per_test_cost_/24029217

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Malhotra, Akash; Thompson, Ryan; De Vos, Margaretha; David, Anura; Schumacher, Samuel; Sohn, Hojoon (2023). Key drivers of per test cost.. PLOS ONE. Dataset

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "Table 1.xls" "https://ndownloader.figshare.com/files/42134724"

文件清单

  • Table 1.xls(5.63 KB)

文件总体积 5.63 KB(源站 API 实测)。

数据说明

Background
Access to drug resistant testing for tuberculosis (TB) remains a challenge in high burden countries. Recently, the World Health Organization approved the use of several moderate complexity automated nucleic acid amplification tests (MC-NAAT) that have performance profiles suitable for placement in a range of TB laboratory tiers to improve drug susceptibility tests (DST) coverage.
Methods
We conducted cost analysis of two MC-NAATs with different testing throughput: Lower Throughput (LT, Results
The base-case per test cost of $18.52 (range: $13.79 - $40.70) for LT test and $15.37 (range: $9.61 - $37.40) for HT test. Per test cost estimates were most sensitive to the number of testing days per week, followed by equipment costs and TB-specific workloads. In general, HT NAATs were cheaper at all testing volume levels, but at lower testing volumes (less than 2,000 per year) LT tests can be cheaper if the durability of the testing system is markedly better and/or procured equipment costs are lower than that of HT NAAT.
Conclusion
Assuming equivalent performance and infrastructural needs, placement strategies for MC-NAATs need to be prioritized by laboratory system’s operational factors, testing demands, and costs.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0290496.t001(source: https://plos.figshare.com/articles/dataset/Key_drivers_of_per_test_cost_/24029217)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案